Newsham enters into strategic alliance

Newsham is currently the 2nd largest supplier of swine genetics in the North American market.

Grimaud is the 2nd largest multi-species poultry genetics group supplying customers in more than 100 countries from its European, US, Brazilian and Asian facilities.

Under the terms of the agreement, Grimaud takes an important interest in Bucolica BV, the Netherlands based company holding a major interest in Newsham. The Newsham original ownership: Bucolica, the Mitchell family, and key Newsham employees remain in control.

This alliance strengthens the acceleration of Newsham's business development outside North America and seeks synergies in the field of research and development.

Various interests
Newsham Choice Genetics has extensive experience in the North American market, supplemented by the recent acquisition of Monsanto Choice Genetics. Newsham will continue to develop its R&D and commercial activities in the swine genetics business through maintaining the original focus on North America as well as pursuing selective expansion in new markets in collaboration with the global network of Grimaud.

Grimaud's investment in Bucolica occurs through its new holding, "Pig Genetics Development Company", which will be the vehicle for its development in the swine genetics business particularly in Europe and Asia, headed by Pieter Seghers who has extensive experience in this industry.

Frédéric Grimaud, president of Groupe Grimaud stated: "I am very pleased with this agreement. It fits perfectly with our long term strategy to develop a global animal multi-species genetics group. This alliance brings a new promising dimension into our Group."

Brent Mitchell, Co-CEO of Newsham commented: "Newsham Choice Genetics has excellent products and technologies which now can be offered to the pig industry on a worldwide basis through the alliance with the Grimaud Group."

Related website:

• Groupe Grimaud

• Newsham Choice Genetics

For the latest pig news, subscribe here